NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Dec 04, 2019 $114.61 $116.59 $114.27 $115.45 1 662 879
Dec 03, 2019 $112.00 $114.13 $111.29 $114.05 1 915 461
Dec 02, 2019 $113.20 $114.96 $112.01 $112.91 1 560 474
Nov 29, 2019 $114.13 $115.00 $113.38 $113.94 609 578
Nov 27, 2019 $114.19 $114.98 $113.25 $114.65 1 004 082
Nov 26, 2019 $113.95 $113.95 $112.22 $113.56 1 313 861
Nov 25, 2019 $110.75 $114.36 $110.01 $114.30 1 724 183
Nov 22, 2019 $109.80 $111.43 $108.67 $111.03 1 165 830
Nov 21, 2019 $108.47 $110.07 $108.00 $109.53 1 615 291
Nov 20, 2019 $110.55 $111.64 $107.59 $108.53 2 506 225
Nov 19, 2019 $109.00 $112.04 $108.00 $110.65 1 795 670
Nov 18, 2019 $108.54 $109.00 $106.78 $107.97 1 393 639
Nov 15, 2019 $106.84 $108.59 $106.02 $108.37 1 653 110
Nov 14, 2019 $107.37 $107.78 $104.52 $105.89 1 603 682
Nov 13, 2019 $109.02 $109.02 $106.73 $107.13 1 422 869
Nov 12, 2019 $109.38 $110.16 $108.44 $109.44 1 329 175
Nov 11, 2019 $110.67 $110.79 $108.35 $109.01 1 328 102
Nov 08, 2019 $107.28 $111.04 $107.00 $110.79 1 255 688
Nov 07, 2019 $106.91 $108.64 $106.77 $108.05 1 421 122
Nov 06, 2019 $107.42 $109.25 $106.39 $106.63 1 512 336
Nov 05, 2019 $108.69 $109.38 $107.10 $107.23 1 560 674
Nov 04, 2019 $110.26 $111.00 $108.37 $108.53 1 309 884
Nov 01, 2019 $106.26 $109.68 $105.62 $109.38 1 889 115
Oct 31, 2019 $106.23 $106.42 $104.45 $105.40 1 277 365
Oct 30, 2019 $107.49 $107.73 $104.96 $106.25 1 053 209
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT